Head to Head Analysis: PainReform (NASDAQ:PRFX) vs TG Therapeutics (NASDAQ:TGTX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
TG Therapeutics (NASDAQ:TGTX) and PainReform (NASDAQ:PRFX) Head-To-Head Review theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
South Korean drugmakers are in a rush to mass-produce antipyretics and antibiotics to keep pace with demand for medicines amid the rise in cases of mycoplasma pneumonia a bacterium that causes respiratory infections and flu viruses during the winter. To avoid a medicine shortage, Daewon Pharmaceutical has started boosting the production of fever medicines and antibiotics, according to reports on Wednesday citin.
Adding certain probiotics to protein have shown to increase protease activity and in turn facilitate a higher rate of amino acid absorption, which could be a new point of market differentiation for the crowded protein supplement market, says South Korea’s Ildong Bioscience.
Analyzing SanBio (OTCMKTS:SNBIF) & TG Therapeutics (NASDAQ:TGTX) kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.